Syndax Pharmaceuticals (SNDX) – New Coverage
-
Mizuho Securities Starts Syndax Pharmaceuticals (SNDX) at Buy, 'Two Near-Term Commercial Opportunities With Upside Drives Our Buy'
-
BofA Securities Starts Syndax Pharmaceuticals (SNDX) at Buy, 'strong NT outlook'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to SNDX Stock Lookup